ITRM
Iterum Therapeutics plcNASDAQHealthcare$0.03+0.00%ClosedMarket Cap: $1.6M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.19
P/S
4.10
EV/EBITDA
-1.05
DCF Value
$-1.10
FCF Yield
-1246.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
-171.3%
Operating Margin
-5202.8%
Net Margin
-6913.1%
ROE
602.4%
ROA
-82.9%
ROIC
-77.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $390.0K | 94.9% | $-7.4M | $-9.0M | $-0.20 | — |
| Q2 2025 | $0.00 | -Infinity% | $-5.5M | $-6.5M | $-0.16 | — |
| Q1 2025 | $0.00 | -Infinity% | $-3.7M | $-4.9M | $-0.14 | — |
| Q4 2024 | $0.00 | NaN% | $-3.7M | $-6.6M | $-0.25 | — |
| FY 2024 | $0.00 | -Infinity% | $-18.7M | $-24.8M | $-1.26 | — |
| Q3 2024 | $0.00 | NaN% | $-4.9M | $-6.1M | $-0.30 | — |
| Q2 2024 | $0.00 | -Infinity% | $-4.0M | $-5.0M | $-0.30 | — |
| Q1 2024 | $0.00 | -Infinity% | $-6.2M | $-7.1M | $-0.46 | — |
| Q4 2023 | $0.00 | -Infinity% | $-11.4M | $-12.4M | $-0.94 | — |
| FY 2023 | $0.00 | -Infinity% | $-47.5M | $-38.4M | $-2.96 | — |
| Q3 2023 | $0.00 | NaN% | $-16.7M | $-3.9M | $-0.30 | — |
| Q2 2023 | $0.00 | NaN% | $-10.8M | $-12.2M | $-0.95 | — |